FDA Recalls Certain Lots of AngioSculpt Percutaneous Transluminal Coronary Catheters

Doctors Guide -- ROCKVILLE, Md -- September 8, 2010 -- The US Food and Drug Administration (FDA) is warning healthcare professionals that the AngioSculpt EX Percutaneous Transluminal Coronary Angioplasty (PTCA) catheters may become separated during use, and fragments of the catheter may become lodged in coronary arteries. This may result in serious injuries, including death.